Search research articles
Contact Us
Filters
Showing results (451-460 of 488) with videos related to
Page
of 49
Sort By:
Journal of Medical Genetics
|
February 7, 2006
Mutations of human TMHS cause recessively inherited non-syndromic hearing loss
M I Shabbir, Z M Ahmed, S Y Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2009
Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases
Roble G Bedolla, Yu Wang, Alfredo Asuncion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 17, 2011
Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3
Liqun Chen, Benjamin A Mooso, Maitreyee K Jathal, et al.
Neurobiology of Aging
|
August 6, 2015
Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer's disease variants
Manja Lehmann, Cindee Madison, Pia M Ghosh, et al.
Journal of the American Heart Association
|
April 1, 2020
Prevalence and Cause of Early Fontan Complications: Does the Lymphatic Circulation Play a Role?
Reena M Ghosh, Heather M Griffis, Andrew C Glatz, et al.
Cardiology in the Young
|
July 18, 2023
Cardiac magnetic resonance predictors for successful primary biventricular repair of unbalanced complete common atrioventricular canal
Andrea L Jones, Brian R White, Reena M Ghosh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2018
Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion
Tsung-Chieh Shih, Ruiwu Liu, Chun-Te Wu, et al.
Plos One
|
August 14, 2015
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy
Chong-Xian Pan, Hongyong Zhang, Clifford G Tepper, et al.
Oncogene
|
July 27, 2017
The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer
L S D'Abronzo, S Bose, M E Crapuchettes, et al.
Scientific Reports
|
June 14, 2023
Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer
Thomas M Steele, Maria Malvina Tsamouri, Salma Siddiqui, et al.
Page
of 49
Search research articles
Search
Showing results (451-460 of 488) with videos related to
Sort By:
Page
of 49
Journal of Medical Genetics
|
February 7, 2006
Mutations of human TMHS cause recessively inherited non-syndromic hearing loss
M I Shabbir, Z M Ahmed, S Y Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2009
Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases
Roble G Bedolla, Yu Wang, Alfredo Asuncion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 17, 2011
Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3
Liqun Chen, Benjamin A Mooso, Maitreyee K Jathal, et al.
Neurobiology of Aging
|
August 6, 2015
Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer's disease variants
Manja Lehmann, Cindee Madison, Pia M Ghosh, et al.
Journal of the American Heart Association
|
April 1, 2020
Prevalence and Cause of Early Fontan Complications: Does the Lymphatic Circulation Play a Role?
Reena M Ghosh, Heather M Griffis, Andrew C Glatz, et al.
Cardiology in the Young
|
July 18, 2023
Cardiac magnetic resonance predictors for successful primary biventricular repair of unbalanced complete common atrioventricular canal
Andrea L Jones, Brian R White, Reena M Ghosh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2018
Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion
Tsung-Chieh Shih, Ruiwu Liu, Chun-Te Wu, et al.
Plos One
|
August 14, 2015
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy
Chong-Xian Pan, Hongyong Zhang, Clifford G Tepper, et al.
Oncogene
|
July 27, 2017
The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer
L S D'Abronzo, S Bose, M E Crapuchettes, et al.
Scientific Reports
|
June 14, 2023
Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer
Thomas M Steele, Maria Malvina Tsamouri, Salma Siddiqui, et al.
Page
of 49